Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19

Available COVID-19 vaccine only provide protection for a limited time due in part to the rapid emergence of viral variants with spike protein mutations, necessitating the generation of new vaccines to combat SARS-CoV-2. Two serologically distinct replication-defective chimpanzee-origin adenovirus (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasanpourghadi, Mohadeseh, Novikov, Mikhail, Ambrose, Robert, Chekaoui, Arezki, Newman, Dakota, Ding, Jianyi, Giles-Davis, Wynetta, Xiang, Zhiquan, Zhou, Xiang Yang, Liu, Qin, Swagata, Kar, Ertl, Hildegund CJ.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Institut Pasteur. Published by Elsevier Masson SAS. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758783/
https://www.ncbi.nlm.nih.gov/pubmed/36539010
http://dx.doi.org/10.1016/j.micinf.2022.105082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758783/
https://www.ncbi.nlm.nih.gov/pubmed/36539010
http://dx.doi.org/10.1016/j.micinf.2022.105082

Ejemplares similares